USP7 is overexpressed in many cancer types, such as ovarian cancer, breast cancer (BC), multiple myeloma, hepatocellular carcinoma, glioblastoma, colorectal cancer (CRC), neuroblastoma, squamous cell carcinoma, and lung cancer [66–73]. Here, USP7 is linked to breast cancer.